Hjem › Nevroendokrin karsinom › Maryland
Kliniske studier for Nevroendokrin karsinom i Maryland
6 studier for Nevroendokrin karsinom søker deltakere på steder i Maryland.
Offisiell studietekst (engelsk)
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 2
Alder 18 til 120 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06406465Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1
Alder 18 til 120 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07509034A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
- National Institutes of Health Clinical Center, Bethesda
RekruttererFase 1
Alder 18 til 120 · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06041516Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservasjonsstudie
Alder 18 til 120 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT05237934Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
- United Theranostics, Glen Burnie
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07278479A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jul. 2026 · NCT05652686Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.